Table 1.

Variations of the main parameters at the end of reperfusion in sham-operated (Sham-saline) subgroup; hypoperfused (Hypo) subgroup; malvidin (Hypo-M₁) subgroup (9 mg/kg b.w.); higher dose malvidin (Hypo-M₂) subgroup (18 mg/kg b.w.); L-NIO (10 mg/kg b.w) and malvidin (18 mg/kg b.w.) subgroup.

Subgroups	Number of animals (n)	Microvascular leakage (NGL)	Leukocyte adhesion (number of leukocyte/100 μm of venular length/30 s)	Capillary perfusion (PCL) % reduction (compared to baseline)	Capillary red blood cell velocity (VRBC mm/s)
Sham-saline	5	0.03 ± 0.01	0.5 ± 0.3	0 ± 4	0.20 ± 0.02
Hypo	5	0.46 ± 0.04§°	10 ± 2§°	48 ± 4§°	0.12 ± 0.03§°
Hypo-M1	5	0.32 ± 0.03§°*	6 ± 1§°*	35 ± 3§°*	0.17 ± 0.01§°*
Hypo-M2	5	0.10 ± 0.02§°*	2 ± 1*	28 ± 4§°*	0.19 ± 0.02*
Hypo-L/M2	5	0.13 ± 0.03§°*+	3.0 ± 1.5*	30 ± 2§°*+	0.24 ± 0.02*

For capillary perfusion, data at the end of reperfusion were compared with those prior to hypoperfusion. Leukocyte adhesion: n = 45 venules for each entry. Data are reported as Mean ± SEM; ^§p < 0.01 vs. Baseline; °p < 0.01 vs. Sham-saline subgroup, *p < 0.01 vs. Hypo subgroup, ⁺p < 0.01 vs. Hypo-M₂ subgroup.